Reports Q4 revenue $10.89B, consensus $10.73B. “Thanks to the strong contributions from our team, we delivered differentiated performance in 2023 and enabled our customers’ success,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific. “We effectively navigated the challenging macroeconomic conditions by leveraging our PPI Business System to deliver strong financial results.” Casper added, “Our proven growth strategy, capital deployment approach, and PPI Business System, continue to position our company for an even brighter future.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMO:
- Is TMO a Buy, Before Earnings?
- Netflix upgraded, Tesla initiated: Wall Street’s top analyst calls
- Thermo Fisher downgraded to Equal Weight on valuation at Barclays
- Thermo Fisher downgraded to Equal Weight from Overweight at Barclays
- Thermo Fisher downgraded to Market Perform from Outperform at Bernstein
